Table 1. Correlation of CAR immunopositivity with clinicopathological parameters.
| Clinicopathological parameters | No. of cases | CAR positive | P-value |
|---|---|---|---|
| <0.0001 | |||
| ‘Normal’ mucosa | 175 | 175 (100%) | |
| Gastric cancer | 196 | 109 (55.6%) | |
| Cancer type | 0.8634 | ||
| Intestinal | 117 | 59 (50.4%) | |
| Diffus | 46 | 24 (52.1%) | |
| Tumour differentiation | 0.0238 | ||
| G1/G2 | 69 | 46 (66.7%) | |
| G3/G4 | 127 | 62 (48.8%) | |
| Tumour infiltration | 0.0349 | ||
| T1/T2 | 127 | 78 (61.4%) | |
| T3/T4 | 69 | 31 (44.9%) | |
| Lymph node metastasis | 0.6383 | ||
| N0 | 57 | 33 (57.9%) | |
| N1-3 | 137 | 74 (54.0%) | |
| Distant metastasis | 0.0016 | ||
| Absent | 54 | 40 (74.0%) | |
| Present | 15 | 4 (26.7%) | |
NOTE: statistically significant correlations are shown in bold face. Results were calculated by Fisher's exact test. Divergent numbers of tissue samples assessable for calculations were due to limited accessibility of clinical information, for example, presence of distant metastasis.